Invention Grant
- Patent Title: Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction
-
Application No.: US17130580Application Date: 2020-12-22
-
Publication No.: US11963965B2Publication Date: 2024-04-23
- Inventor: Preston E. Bratcher , Pamela L. Zeitlin
- Applicant: National Jewish Health
- Applicant Address: US CO Denver
- Assignee: National Jewish Health
- Current Assignee: National Jewish Health
- Current Assignee Address: US CO Denver
- Agency: Sheridan Ross P.C.
- Main IPC: A61K31/558
- IPC: A61K31/558 ; A61K31/352 ; A61K31/404 ; A61K31/4155 ; A61K31/443 ; A61K31/4439 ; A61K31/47 ; A61K31/502 ; A61K45/06 ; A61P11/00
Abstract:
Methods of treating cystic fibrosis transmembrane conductance regulator (CFTR)-mediated disease, such as cystic fibrosis, in patients with residual function mutations.
Public/Granted literature
- US20210196728A1 METHODS OF TREATING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) DYSFUNCTION Public/Granted day:2021-07-01
Information query
